Defining high, medium and low impact prognostic factors for developing multiple sclerosisMar Tintoré, Xavier Montalbán, Àlex Rovira et al.|Brain|2015Cited by 520
Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple SclerosisCarmen Tur, Xavier Montalbán, Annalaura Salerno et al.|JAMA Neurology|2022Cited by 278
Measures in the first year of therapy predict the response to interferon β in MSJordi Río, Xavier Montalbán, Joaquín Castilló et al.|Multiple Sclerosis Journal|2009Cited by 242
Brainstem lesions in clinically isolated syndromesMar Tintoré, Xavier Montalbán, Àlex Rovira et al.|Neurology|2010Cited by 195
The value of oligoclonal bands in the multiple sclerosis diagnostic criteriaGeorgina Arrambide, Xavier Montalbán, Mar Tintoré et al.|Brain|2018Cited by 158